VALUE

Brief Description Of Study

The purpose of this study is to see how the investigational study drug lowers triglycerides in conjunction with statin in individuals with high triglycerides.

Clinical Study Identifier: TX1074

Detailed Study Description

If you are enrolled in this study you will be asked to come to the research clinic for up to 7 visits over 4 months after the screening period. The visits include two 16-hour outpatient visits, two 12-hour outpatient visits, and one to three 1-hour visits. You will take four capsules of the study drug as well as the statin medication during the study. Visits will involve fasting bloodwork, vitals, and other research tests. You will be reimbursed for your time and efforts.

Additional Information About The Study

Eligible subjects may be compensated up to $925 for their time and travel. For more information, please contact Katy at (215) 746-8337 or antr@mail.med.upenn.edu. Triglycerides are a type of fat in the blood that may raise the risk of cardiovascular disease. Statins are a group of drugs used to lower cholesterol which have been established as an effective method of reducing heart attack, stroke and cardiac-related death among patients with known heart disease and those who are at risk for developing heart disease.

Contact research investigator to learn more about this study by filling out the form below.


To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: VALUE
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.